S-8


As filed with the Securities and Exchange Commission on February 29, 2016
Registration No. 333-


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM S-8

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
________________
CHIMERIX, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
33-0903395
(State or Other Jurisdiction of Incorporation or Organization)
(I.R.S. Employer Identification No.)

2505 Meridian Parkway, Suite 100
Durham, NC 27713
(Address of Principal Executive Offices)
________________
2013 Equity Incentive Plan
2013 Employee Stock Purchase Plan
(Full Title of the Plan)

M. Michelle Berrey, M.D., M.P.H.
President and Chief Executive Officer
Chimerix, Inc.
2505 Meridian Parkway, Suite 100
Durham, NC 27713
(Name and Address of Agent for Service)

(919) 806-1074
(Telephone Number, Including Area Code, of Agent for Service)
________________
Copies to:
Timothy W. Trost
Senior Vice President, Chief Financial Officer
and Corporate Secretary
Chimerix, Inc.
2505 Meridian Parkway, Suite 100
Durham, NC 27713
(919) 806-1074
Jason L. Kent, Esq.
Nathan J. Nouskajian, Esq.
Cooley LLP
4401 Eastgate Mall
San Diego, CA 92121
(858) 550-6000
________________
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 
 
 
 
Large accelerated filer R
Accelerated filer £
Non-accelerated filer £
Smaller reporting company £
 
 
(Do not check if a smaller reporting company)
 

 
 
 
126736197 v2





CALCULATION OF REGISTRATION FEE
Title of
Securities to
be Registered
 
Amount to be
Registered 1
 
Proposed
Maximum
Offering
Price per Share (2)
 
Proposed Maximum
Aggregate
Offering Price (2)
 
Amount of
Registration Fee
2013 Equity Incentive Plan
Common Stock, $0.001 par value per share
 
1,846,501 shares (3)
 
$4.705
 
$8,687,787.21
 
$874.87
2013 Employee Stock Purchase Plan
Common Stock, $0.001 par value per share
 
422,535 shares (4)
 
$4.705
 
$1,988,027.18
 
$200.20
Total
 
2,269,036 shares
 
N/A
 
$10,675,814.39
 
$1,075.07

(1)
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Registrant’s common stock (the “Common Stock”) that become issuable under the plans by reason of any stock dividend, stock split, recapitalization or other similar transaction.

(2)
This estimate is made pursuant to Rule 457(c) and Rule 457(h)(1) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Common Stock on February 24, 2016, as reported on the Nasdaq Global Market.

(3) Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrant’s 2013 Equity Incentive Plan (the “EIP”) on January 1, 2016 pursuant to an “evergreen” provision contained in the EIP. Pursuant to such provision, on January 1st of each year commencing in 2014 and ending on (and including) January 1, 2023, the number of shares authorized for issuance under the EIP is automatically increased by a number equal to: (a) 4% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year; or (b) such lesser number of shares of Common Stock as is determined by the Registrant’s board of directors (the “Board”) for the applicable year.

(4)
Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrant’s 2013 Employee Stock Purchase Plan (the “ESPP”) on January 1, 2016 pursuant to an “evergreen” provision contained in the ESPP. Pursuant to such provision, on January 1st of each year commencing in 2014 and ending on (and including) January 1, 2023, the number of shares authorized for issuance under the ESPP is automatically increased by a number equal to the least of: (a) 1% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year; (b) 422,535 shares; or (c) a number determined by the Board that is less than (a) and (b).





























126736197 v2





INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION
STATEMENT ON FORM S-8

This Registration Statement on Form S-8 is being filed for the purpose of increasing the number of securities of the same class as other securities for which Registration Statements on Form S-8 relating to the same benefit plans are effective. The Registrant previously registered shares of its Common Stock for issuance under the EIP and the ESPP under Registration Statements on Form S-8 filed with the Securities and Exchange Commission on April 11, 2013 (File No. 333-187860), March 7, 2014 (File No. 333-194408) and March 6, 2015 (File No. 333-202582). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statements referenced above.
Item 8.
Exhibits.
Exhibits:
 
Description
4.1
 
Amended and Restated Certificate of Incorporation of the Registrant. (1)
4.2
 
Amended and Restated Bylaws of the Registrant. (1)
4.3
 
Form of Common Stock Certificate of the Registrant. (2)
5.1
 
Opinion of Cooley LLP.
23.1
 
Consent of Ernst & Young LLP, an Independent Registered Public Accounting Firm.
23.2
 
Consent of Cooley LLP. Reference is made to Exhibit 5.1.
24.1
 
Power of Attorney. Reference is made to the signature page hereto.
99.1
 
Chimerix, Inc. 2013 Equity Incentive Plan. (3)
99.2
 
Form of Stock Option Agreement, Notice of Exercise and Form of Stock Option Grant Notice under Chimerix, Inc. 2013 Equity Incentive Plan. (2)
99.3
 
Chimerix, Inc. 2013 Employee Stock Purchase Plan. (2)
____________________

(1)
Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on April 16, 2013.
(2)
Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (No. 333-187145), filed on March 8, 2013, as amended.
(3)
Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on June 23, 2014.

































126736197 v2






SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Durham, State of North Carolina, on February 29, 2016.

 
 
 
 
 
 
 
 
 
 
CHIMERIX, INC.
 
 
 
 
 
 
 
 
 
By:
 
/s/    M. Michelle Berrey
 
 
 
 
 
M. Michelle Berrey, M.D., MPH
 
 
 
 
 
President & Chief Executive Officer




 
 
 











































126736197 v2





POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints M. Michelle Berrey, M.D., M.P.H. and Timothy W. Trost, and each of them, as his true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him and in his name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
 
Title
 
Date
 
 
 
 
 
/s/    M. Michelle Berrey
 
President, Chief Executive Officer and
 
February 29, 2016
M. Michelle Berrey, MD, MPH
 
Member of the Board of Directors
 
 
 
 
(Principal Executive Officer)
 
 
 
 
 
 
 
/s/    Timothy W. Trost
 
Senior Vice President, Chief Financial Officer
 
February 29, 2016
Timothy W. Trost
 
and Corporate Secretary
 
 
 
 
 (Principal Financial and Accounting Officer)
 
 
 
 
 
 
 
/s/    Ernest Mario
 
 
 
 
Ernest Mario, PhD
 
Chairman of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    James M. Daly
 
 
 
 
James M. Daly
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    Martha J. Demski
 
 
 
 
Martha J. Demski
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    Catherine L. Gilliss
 
 
 
 
Catherine L. Gilliss, PhD, RN, FAAN
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    John M. Leonard
 
 
 
 
John M. Leonard, MD
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    C. Patrick Machado
 
 
 
 
C. Patrick Machado
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    James Niedel
 
 
 
 
James Niedel, MD, PhD
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/   Ronald C. Renaud. Jr
 
 
 
 
Ronald C. Renaud, Jr
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/    Lisa Ricciardi
 
 
 
 
Lisa Ricciardi
 
Member of the Board of Directors
 
February 29, 2016
 
 
 
 
 
/s/ Timothy J. Wollaeger
 
 
 
 
Timothy J. Wollaeger
 
Member of the Board of Directors
 
February 29, 2016
126736197 v2





EXHIBIT INDEX

 
 
 
Exhibits:
Description
4.1
Amended and Restated Certificate of Incorporation of the Registrant. (1)
4.2
Amended and Restated Bylaws of the Registrant. (1)
4.3
Form of Common Stock Certificate of the Registrant. (2)
5.1
Opinion of Cooley LLP.
23.1
Consent of Ernst & Young LLP, an Independent Registered Public Accounting Firm.
23.2
Consent of Cooley LLP. Reference is made to Exhibit 5.1.
24.1
Power of Attorney. Reference is made to the signature page hereto.
99.1
Chimerix, Inc. 2013 Equity Incentive Plan. (3)
99.2
Form of Stock Option Agreement, Notice of Exercise and Form of Stock Option Grant Notice under Chimerix, Inc. 2013 Equity Incentive Plan. (2)
99.3
Chimerix, Inc. 2013 Employee Stock Purchase Plan. (2)
____________________

(1)
Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on April 16, 2013.
(2)
Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (No. 333-187145), filed on March 8, 2013, as amended.
(3)
Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on June 23, 2014.









































126736197 v2